Tower View Wealth Management LLC Sells 39 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tower View Wealth Management LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,709 shares of the medical equipment provider’s stock after selling 39 shares during the quarter. Tower View Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,805,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. LVW Advisors LLC increased its holdings in Intuitive Surgical by 13.3% in the 1st quarter. LVW Advisors LLC now owns 1,201 shares of the medical equipment provider’s stock valued at $479,000 after buying an additional 141 shares during the period. Aviance Capital Partners LLC acquired a new position in Intuitive Surgical in the first quarter worth about $612,000. Diversified Trust Co lifted its stake in Intuitive Surgical by 7.9% during the first quarter. Diversified Trust Co now owns 6,574 shares of the medical equipment provider’s stock worth $2,624,000 after purchasing an additional 479 shares during the period. Miracle Mile Advisors LLC boosted its holdings in Intuitive Surgical by 2.8% during the first quarter. Miracle Mile Advisors LLC now owns 1,478 shares of the medical equipment provider’s stock valued at $590,000 after purchasing an additional 40 shares in the last quarter. Finally, Claro Advisors LLC grew its stake in shares of Intuitive Surgical by 25.0% in the 1st quarter. Claro Advisors LLC now owns 819 shares of the medical equipment provider’s stock valued at $327,000 after purchasing an additional 164 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 51,816 shares of company stock valued at $25,230,649 over the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.1 %

Shares of NASDAQ ISRG opened at $512.02 on Monday. The company has a fifty day moving average price of $487.98 and a 200 day moving average price of $443.05. The firm has a market cap of $182.37 billion, a PE ratio of 82.20, a PEG ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34.

Analyst Ratings Changes

Several equities analysts recently commented on ISRG shares. Stifel Nicolaus raised their target price on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Morgan Stanley lifted their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Leerink Partners boosted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Raymond James increased their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.